Ennis & Ennis, P.A. Press releases11 - 20 of 91 Press Releases
Apr 16, 2013
Ennis & Ennis, P.A. reports that the FDA is warning of the dangers of DMAA and is working to ensure that any dietary supplements containing the stimulant, dimethylamylamine (DMAA) will no longer be distributed or sold in the U.S. marketplace.
Apr 11, 2013
Ennis & Ennis, P.A. reports that the second trial alleging that osteoporosis drug Fosamax caused a femur fracture began this week before U.S. District Judge Joel Pisano in Trenton, New Jersey.
Mar 20, 2013
Actos manufacturer, Takeda is fully embroiled in the first of over 3,000 Actos lawsuits to go to trial claiming the diabetes drug causes bladder cancer.
Mar 18, 2013
The nation’s first trial involving claims that Fosamax caused femur fractures began this week in New Jersey Superior Court, Atlantic County. According to the Plaintiff, Christina Su, Merck& Co.
Feb 28, 2013
Ennis & Ennis, P.A. reports on the Punitive Damage Award against J&J in the first transvaginal mesh lawsuit.
Feb 25, 2013
Ennis & Ennis, P.A. reports on the trial and verdict in the first Ethicon transvaginal mesh lawsuit.
Feb 25, 2013
U.S. based Affymax, Inc., and Takeda Pharmaceutical Co., Japan’s biggest drug manufacturer, voluntarily recalled all lots of an anemia treatment for kidney dialysis patients called Omontys after reports of injuries and death.
Feb 21, 2013
The first trial of many lawsuits alleging that diabetes medication Actos causes bladder cancer is scheduled to begin this week in Los Angeles.
Feb 13, 2013
Over 10,000 women have filed claims based on injuries received from Yaz, Yasmin and Ocella birth control pills, making it one of the largest mass torts in recent history.
Feb 12, 2013
In the first trial against Johnson & Johnson’s Ethicon unit, maker of the Gynecare Prolift vaginal mesh, testimony has revealed that Ethicon ignored warnings, from both internal and outside sources about potential dangers of the mesh.